Mulibrey nanism

From WikiMD's Food, Medicine & Wellness Encyclopedia

Mulibrey nanism is a rare, autosomal recessive disorder characterized by growth failure of muscle, liver, brain, and eye; hence the acronym MULIBREY (MUscle-LIver-BRain-EYe). The disorder was first described in 1973 by Finnish pediatrician Jukka Kallijärvi. It is also known as Perheentupa syndrome after the Finnish pediatrician Jaakko Perheentupa who further characterized the disorder.

Signs and Symptoms[edit | edit source]

The most common symptoms of Mulibrey nanism include severe growth failure and distinctive facial features. These features may include a triangular face, a pointed chin, a large nose, and eyes that appear to be spaced widely apart. Other symptoms may include heart abnormalities, liver abnormalities, muscle weakness, and a variety of other symptoms.

Causes[edit | edit source]

Mulibrey nanism is caused by mutations in the TRIM37 gene. This gene provides instructions for making a protein that is involved in the normal functioning of the cell's machinery for protein degradation. Mutations in the TRIM37 gene disrupt the normal functioning of this machinery, leading to the accumulation of abnormal proteins and the symptoms of Mulibrey nanism.

Diagnosis[edit | edit source]

The diagnosis of Mulibrey nanism is based on the presence of characteristic clinical features and confirmed by genetic testing. The genetic test involves sequencing the TRIM37 gene to identify mutations.

Treatment[edit | edit source]

There is currently no cure for Mulibrey nanism. Treatment is symptomatic and supportive, and may include growth hormone therapy to improve growth, and surgery to correct heart abnormalities.

Epidemiology[edit | edit source]

Mulibrey nanism is extremely rare, with fewer than 200 cases reported worldwide. The majority of these cases have been reported in Finland, where the disorder is estimated to affect 1 in 50,000 individuals.

See also[edit | edit source]

References[edit | edit source]

Mulibrey nanism Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD